Sufentanil Citrate Injection, Solution
Product Images NDC 0409-3382

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Sufentanil Citrate (NDC 0409-3382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Sufentanil 01)

FDA Label Image

Logo (Sufentanil 02)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Principal Display Panel (1 mL Vial Label)
Suftentanil Citrate Injection, USP is a preservative-free medicine distributed by Hospira, Inc. It is used for intravenous and epidural use at a concentration of 50 mcg/mL. The product comes with the identification codes RL-7896 and HHA-HHH-AA DMMMYYYY. The last line displays a limited GS1 Databar of 7.5 Mil with the number (01)10304093382119.*
FDA Label Image

Principal Display Panel (1 mL Vial Carton)

Principal Display Panel (1 mL Vial Carton)
This appears to be a product description for a medication containing sufenatil citrate, intended for intravenous and epidural use. The medication comes in 10 single-dose fliptop vials each containing 50 meg/mL of the active ingredient. There is no preservative in the medication. The medication is distributed by Hospira Inc. in Lake Forest, IL, and has an NDC of 0408-3382-21. The lot number is HH#HHHAA and the expiration date is DMMMYYYY. The storage temperature is controlled to 20-25°C (68-77°F) in a USP-controlled room. There is also a GTIN number for the product.*
FDA Label Image

Principal Display Panel (2 mL Vial Label)

Principal Display Panel (2 mL Vial Label)
This is a description of SUFENTANIL CITRATE Inj, USP, a medication used for intravenous and epidural use that is distributed by Hospira, Inc. The label indicates the medication is preservative-free and includes a lot number and expiration date. The text also includes a barcode in the GS1 Databar Limited format, but no additional information is given.*
FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Principal Display Panel (2 mL Vial Carton)
SUFENTANIL CITRATE Inj., USP is a prescription drug that comes in a 2mL vial. The drug should be stored at a temperature between 10°C to 25°C and should be protected from light. It must be administered via intravenous or epidural injection. The dosage should be determined by the doctor. The drug is distributed by Hospira Inc. and is available in a pack of 10 vials with a flip-top lid. The drug must be discarded if the prescription is not used in its entirety. The GTIN number is given as 10304093382225, and LOT number is mentioned as HHHHHAA.*
FDA Label Image

Principal Display Panel (5 mL Vial Label)

Principal Display Panel (5 mL Vial Label)
This is a medication label for a single-dose injection containing 250 mcg/5 mL Isufentanil citrate. The medication is Rx only and distributed by Hospira, Inc. It is for intravenous and epidural use and must be protected from light. The label also indicates the manufacturer's name and address, as well as the product's lot number and expiry date.*
FDA Label Image

Principal Display Panel (5 mL Vial Carton)

Principal Display Panel (5 mL Vial Carton)
This is a description of a medication contained in 10 single-dose flip-top vials of 5mL each. The medication is SuFentanil Citrate Injection for Intravenous and Epidural use, containing 250 mcg of suFentanil per 5mL. It is preservative-free and must be protected from light, and retained in carton until use. The medication contains suFentanil citrate equivalent to 50mcg/mL, with possible sodium hydroxide and/or hydrochloric acid for pH adjustment. It is sterile and non-pyrogenic, and should be used with aseptic technique. The unused portion should be discarded, and the medication should be stored at 20 to 25°C (68 to 77°F) until use. The manufacturer is Hospira, Inc.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.